Sarah James
Stock Analyst at Cantor Fitzgerald
(0.99)
# 1950
Out of 5,329 analysts
297
Total ratings
28.37%
Success rate
-2.96%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HUM Humana | Reiterates: Neutral | 290 290 | 256.99 | 12.84% | 21 | May 1, 2025 | |
ELV Elevance Health | Reiterates: Overweight | 485 485 | 410.89 | 18.04% | 20 | Apr 23, 2025 | |
CI Cigna Group | Maintains: Overweight | 350 365 | 344.62 | 5.91% | 21 | Mar 20, 2025 | |
TBRG TruBridge | Maintains: Overweight | 20 29 | 26.31 | 10.22% | 6 | Mar 11, 2025 | |
LFMD LifeMD | Reiterates: Overweight | 15 15 | 7.47 | 100.8% | 11 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 177 177 | 145.11 | 21.98% | 20 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 346.73 | 16.81% | 19 | Jan 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 700 700 | 399.15 | 75.37% | 17 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 90 90 | 60.22 | 49.45% | 12 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 52 52 | 23.14 | 124.72% | 13 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 17 | 23.06 | -26.28% | 14 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 219 219 | 177.11 | 23.65% | 24 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 406 406 | 314.83 | 28.96% | 11 | Oct 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 43 43 | 22.71 | 89.34% | 12 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 15 15 | n/a | n/a | 6 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 4.08 | 292.16% | 6 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 62 62 | 69.97 | -11.39% | 14 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 2.22 | 125.23% | 8 | Sep 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 7.02 | 42.45% | 2 | Aug 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 101 101 | 95.69 | 5.55% | 7 | Jul 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 133 | 141.49 | -6% | 6 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 42 | 14.82 | 183.4% | 3 | Aug 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | 3.09 | 61.81% | 2 | Sep 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 5 | 4.6 | 8.7% | 2 | Aug 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 34 | n/a | n/a | 3 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 57 | n/a | n/a | 2 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 21 | 15.44 | 36.01% | 3 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 15 18 | n/a | n/a | 2 | Jul 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 39 | 53.27 | -26.79% | 1 | Aug 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 212 206 | n/a | n/a | 3 | Oct 31, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 151 0 | n/a | n/a | 2 | Jan 3, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 193 | 65.01 | 196.88% | 2 | Sep 15, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Mar 1, 2017 |